| Caroline Werner, MD | |
|
1120 Shackelford Rd, Florissant, MO 63031-4369 | |
| (314) 921-4420 | |
| (314) 921-6086 |
| Full Name | Caroline Werner |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 40 Years |
| Location | 1120 Shackelford Rd, Florissant, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538151097 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | R1F05 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Depaul Health Center | Bridgeton, MO | Hospital |
| St Lukes Hospital | Chesterfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Medical Group Inc | 6608776299 | 491 |
News Archive
How Medicare's Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment - This study examines the impact that Medicare payment cuts for chemotherapy drugs had on treatment for Medicare beneficiaries with newly diagnosed lung cancer, before and after implementation of the June 2005 new payment system, focusing on five chemotherapy drugs "in common use singly or jointly for lung cancer..."
Astellas Pharma Canada, Inc. announced today that Health Canada has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
Vaccinations are the safest way to protect against disease. However, many vaccines become ineffective when exposed to room temperature or heat.
Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration has approved the supplemental new drug application for NEXTERONE (amiodarone HCl) Premixed Injection, the first and only premixed intravenous (IV) bag formulation of the antiarrhythmic agent amiodarone IV.
› Verified 7 days ago
| Entity Name | Ssm Health Care St Louis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275586174 PECOS PAC ID: 7810800737 Enrollment ID: O20031118000393 |
News Archive
How Medicare's Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment - This study examines the impact that Medicare payment cuts for chemotherapy drugs had on treatment for Medicare beneficiaries with newly diagnosed lung cancer, before and after implementation of the June 2005 new payment system, focusing on five chemotherapy drugs "in common use singly or jointly for lung cancer..."
Astellas Pharma Canada, Inc. announced today that Health Canada has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
Vaccinations are the safest way to protect against disease. However, many vaccines become ineffective when exposed to room temperature or heat.
Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration has approved the supplemental new drug application for NEXTERONE (amiodarone HCl) Premixed Injection, the first and only premixed intravenous (IV) bag formulation of the antiarrhythmic agent amiodarone IV.
› Verified 7 days ago
| Entity Name | Ssm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700966207 PECOS PAC ID: 6608776299 Enrollment ID: O20040729001034 |
News Archive
How Medicare's Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment - This study examines the impact that Medicare payment cuts for chemotherapy drugs had on treatment for Medicare beneficiaries with newly diagnosed lung cancer, before and after implementation of the June 2005 new payment system, focusing on five chemotherapy drugs "in common use singly or jointly for lung cancer..."
Astellas Pharma Canada, Inc. announced today that Health Canada has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
Vaccinations are the safest way to protect against disease. However, many vaccines become ineffective when exposed to room temperature or heat.
Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration has approved the supplemental new drug application for NEXTERONE (amiodarone HCl) Premixed Injection, the first and only premixed intravenous (IV) bag formulation of the antiarrhythmic agent amiodarone IV.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caroline Werner, MD Po Box 955534, Saint Louis, MO 63195-5534 Ph: () - | Caroline Werner, MD 1120 Shackelford Rd, Florissant, MO 63031-4369 Ph: (314) 921-4420 |
News Archive
How Medicare's Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment - This study examines the impact that Medicare payment cuts for chemotherapy drugs had on treatment for Medicare beneficiaries with newly diagnosed lung cancer, before and after implementation of the June 2005 new payment system, focusing on five chemotherapy drugs "in common use singly or jointly for lung cancer..."
Astellas Pharma Canada, Inc. announced today that Health Canada has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
Vaccinations are the safest way to protect against disease. However, many vaccines become ineffective when exposed to room temperature or heat.
Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration has approved the supplemental new drug application for NEXTERONE (amiodarone HCl) Premixed Injection, the first and only premixed intravenous (IV) bag formulation of the antiarrhythmic agent amiodarone IV.
› Verified 7 days ago
Dr. Kristin Leigh Wheeler, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1120 Shackelford Rd, Florissant, MO 63031 Phone: 314-921-4420 | |
Dr. Hamid A. Hosseini, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1224 Graham Rd, Suite 1104, Florissant, MO 63031 Phone: 314-831-6517 Fax: 314-831-3421 |